Khiron Life Sciences Corp.
KHRNH.V
TSX
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -24.19M | -24.10M | -26.30M | -26.37M | -12.71M |
| Total Depreciation and Amortization | 1.53M | 1.37M | 1.13M | 890.00K | 1.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.25M | 10.60M | 12.19M | 11.07M | -2.67M |
| Change in Net Operating Assets | -337.60K | 391.10K | 1.04M | -1.80M | -2.32M |
| Cash from Operations | -11.74M | -11.73M | -11.94M | -16.20M | -16.52M |
| Capital Expenditure | -2.04M | -1.62M | -1.55M | -1.39M | -1.06M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 6.30K | -- | -- |
| Cash Acquisitions | -271.40K | -271.40K | -271.40K | -271.40K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -138.50K | -66.40K | 200.00 | 200.00 | -22.10K |
| Cash from Investing | -2.45M | -1.95M | -1.82M | -1.66M | -1.08M |
| Total Debt Issued | 634.50K | 109.50K | 108.50K | -500.00 | 169.00K |
| Total Debt Repaid | 253.00K | 168.00K | -161.00K | -107.00K | -960.90K |
| Issuance of Common Stock | 4.61M | 16.95M | 12.35M | 12.35M | 24.71M |
| Repurchase of Common Stock | -5.46M | -5.46M | -5.46M | -5.46M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.72M | 3.19M | 3.94M | 3.94M | -943.00K |
| Cash from Financing | 3.71M | 11.84M | 8.54M | 8.50M | 17.89M |
| Foreign Exchange rate Adjustments | -102.70K | -1.10M | -823.40K | -901.60K | -679.40K |
| Miscellaneous Cash Flow Adjustments | 800.00 | 145.30K | 144.50K | 144.50K | 717.80K |
| Net Change in Cash | -10.59M | -2.80M | -5.90M | -10.12M | 334.20K |
